Collectively, these results suggest that the rs36084323 polymorphism confers increased basal PD-1 expression at early-to-intermediate stages of CD4+ T-cell activation and that this is associated with increased risk of RA. This evidence concerns the gene CD4 and rheumatoid arthritis.